European Innovation Council (EIC)

Hero top shape asset
Hero ImageEuropean Innovation Council (EIC)
Hero Radius Shape
Hero bottom shape asset
Hero top shape asset
Hero ImageEuropean Innovation Council (EIC)
Hero Radius Shape
Hero bottom shape asset

EIC Transition Grant

Clarity Sensors is delighted to be the recipient of a €2.5M EIC Transition grant in May 2025. The EIC Transition grant is a program under Horizon Europe 
that provides funding and support to advance innovative technologies from a lab-based proof-of-concept to a market-ready stage. It bridges the gap between early-stage research and later commercialisation by funding activities like prototyping, modeling, and validation in real-world environments. The grant also supports business development to ensure the technology has a viable path to market, with funding of up to €2.5 million available.

Previously The Stranks Lab (at University of Cambridge, Department of Chemical Engineering & Biotechnology) were recipients of grants from Horizon Europe for development of perovskite photon-counting detectors based on halide perovskites, which successfully demonstrated their potential to be high performing and cost-effective X-ray detectors.

In the PERFORM project we are developing advanced photon-counting detectors with halide perovskite semiconductors. Our patented monolithic integration process, combined with leading perovskite quality, positions Clarity Sensors to deliver industry-leading photon-counting detectors, targeting the highest image resolution and lowest effective dose. Through projects such as our ERC Proof-of-Concept (PEROVSCI) project, we have demonstrated a stable, single-pixel halide perovskite photon-counting detector and filed key intellectual property culminating in the fabrication of the first monolithic perovskite PCD on a multi-pixel ASIC. In PERFORM, we will further develop our technology and business operations to position Clarity Sensors for investment and joint development. This will include optimising our current photon-counting detector systems and developing our working demonstrator, PRISM-X, which will be validated against commercial technologies in clinical settings to reach TRL-5.

Details of the PERFORM project can be found here.